”The invisible”: Participant's experiences in clinical trials

Background: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. Methodology: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra...

Full description

Bibliographic Details
Main Authors: Sarojini Nadimpally, Divya Bhagianadh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Perspectives in Clinical Research
Subjects:
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=5;epage=10;aulast=Nadimpally
id doaj-e79036f922ba40eaa8ac1dbe47d4d8c6
record_format Article
spelling doaj-e79036f922ba40eaa8ac1dbe47d4d8c62020-11-24T21:23:52ZengWolters Kluwer Medknow PublicationsPerspectives in Clinical Research2229-34852017-01-018151010.4103/2229-3485.198550”The invisible”: Participant's experiences in clinical trialsSarojini NadimpallyDivya BhagianadhBackground: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. Methodology: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra and Andhra Pradesh. In addition to CT participants, other key informants including investigators, representatives of Contract Research Organizations (CROs), sponsor, Ethics Committee (EC) members etc. were also interviewed to develop a comprehensive understanding of the functioning of the CT sector. Findings and Discussion: The paper describes the perspectives of participants on the relevant aspects of recruitment into CTs, reasons for participation in CTs, informed consent, adverse events and compensation. The role played by the push and pull factors in recruitment, the information asymmetry, the power imbalance between the health-care provider and seeker, the role of sociocultural factors, etc., are explored in the paper. Combined with the insights from other stakeholders, the study gives an understanding about the chasm between regulations and realities in the Indian CT sector. Further, the paper briefly explores the recent changes and amendments in the laws governing the CT sector that is aimed at improving the conduct of CTs and uphold the rights of participants. Conclusion: Participants are the most important stakeholders in a CT setting. It is imperative that their voices are heard and their rights upheld for the ethical conduct of CTs.http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=5;epage=10;aulast=NadimpallyClinical trialscompensationinformed consentparticipantsrecruitment
collection DOAJ
language English
format Article
sources DOAJ
author Sarojini Nadimpally
Divya Bhagianadh
spellingShingle Sarojini Nadimpally
Divya Bhagianadh
”The invisible”: Participant's experiences in clinical trials
Perspectives in Clinical Research
Clinical trials
compensation
informed consent
participants
recruitment
author_facet Sarojini Nadimpally
Divya Bhagianadh
author_sort Sarojini Nadimpally
title ”The invisible”: Participant's experiences in clinical trials
title_short ”The invisible”: Participant's experiences in clinical trials
title_full ”The invisible”: Participant's experiences in clinical trials
title_fullStr ”The invisible”: Participant's experiences in clinical trials
title_full_unstemmed ”The invisible”: Participant's experiences in clinical trials
title_sort ”the invisible”: participant's experiences in clinical trials
publisher Wolters Kluwer Medknow Publications
series Perspectives in Clinical Research
issn 2229-3485
publishDate 2017-01-01
description Background: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. Methodology: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra and Andhra Pradesh. In addition to CT participants, other key informants including investigators, representatives of Contract Research Organizations (CROs), sponsor, Ethics Committee (EC) members etc. were also interviewed to develop a comprehensive understanding of the functioning of the CT sector. Findings and Discussion: The paper describes the perspectives of participants on the relevant aspects of recruitment into CTs, reasons for participation in CTs, informed consent, adverse events and compensation. The role played by the push and pull factors in recruitment, the information asymmetry, the power imbalance between the health-care provider and seeker, the role of sociocultural factors, etc., are explored in the paper. Combined with the insights from other stakeholders, the study gives an understanding about the chasm between regulations and realities in the Indian CT sector. Further, the paper briefly explores the recent changes and amendments in the laws governing the CT sector that is aimed at improving the conduct of CTs and uphold the rights of participants. Conclusion: Participants are the most important stakeholders in a CT setting. It is imperative that their voices are heard and their rights upheld for the ethical conduct of CTs.
topic Clinical trials
compensation
informed consent
participants
recruitment
url http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=1;spage=5;epage=10;aulast=Nadimpally
work_keys_str_mv AT sarojininadimpally theinvisibleparticipantsexperiencesinclinicaltrials
AT divyabhagianadh theinvisibleparticipantsexperiencesinclinicaltrials
_version_ 1725990748703162368